Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
20,612,275
-
Share change
-
-43,959
-
Total reported value
-
$1,283,931,088
-
Put/Call ratio
-
144%
-
Price per share
-
$62.29
-
Number of holders
-
191
-
Value change
-
-$4,282,796
-
Number of buys
-
111
-
Number of sells
-
82
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2014
As of 30 Jun 2014,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,612,275 shares.
The largest 10 holders included
BVF INC/IL, FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, BlackRock Fund Advisors, Knott David M, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, BlackRock Institutional Trust Company, N.A., State Street Corp, and CARDINAL CAPITAL MANAGEMENT LLC /CT.
This page lists
191
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.